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Abstract
Background: Adaptation to low oxygen by changing gene expression is vitally important for cell survival and tissue
development. The sprouting of new blood vessels, initiated from endothelial cells, restores the oxygen supply of ischemic
tissues. In contrast to the transcriptional response induced by hypoxia, which is mainly mediated by members of the HIF
family, there are only few studies investigating alternative splicing events. Therefore, we performed an exon array for the
genome-wide analysis of hypoxia-related changes of alternative splicing in endothelial cells.
Methodology/Principal findings: Human umbilical vein endothelial cells (HUVECs) were incubated under hypoxic
conditions (1% O2) for 48 h. Genome-wide transcript and exon expression levels were assessed using the Affymetrix
GeneChip Human Exon 1.0 ST Array. We found altered expression of 294 genes after hypoxia treatment. Upregulated genes
are highly enriched in glucose metabolism and angiogenesis related processes, whereas downregulated genes are mainly
connected to cell cycle and DNA repair. Thus, gene expression patterns recapitulate known adaptations to low oxygen
supply. Alternative splicing events, until now not related to hypoxia, are shown for nine genes: six which are implicated in
angiogenesis-mediated cytoskeleton remodeling (cask, itsn1, larp6, sptan1, tpm1 and robo1); one, which is involved in the
synthesis of membrane-anchors (pign) and two universal regulators of gene expression (cugbp1 and max).
Conclusions/Significance: For the first time, this study investigates changes in splicing in the physiological response to
hypoxia on a genome-wide scale. Nine alternative splicing events, until now not related to hypoxia, are reported,
considerably expanding the information on splicing changes due to low oxygen supply. Therefore, this study provides
further knowledge on hypoxia induced gene expression changes and presents new starting points to study the hypoxia
adaptation of endothelial cells.
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Introduction
The sufficient supply of all cells of the body with oxygen is of
vital importance and vessel growth is essential to promote blood
supply after tissue ischemia. Particularly, the proliferation,
migration and sprouting of endothelial cells from existing
capillaries, a process termed angiogenesis, increases blood supply
in ischemic tissues [1,2]. On the other hand, angiogenesis is
required for tumor growth and therefore is a target for anti-tumor
therapies. The master regulator of the cellular response to hypoxia
is the transcription factor HIF1 (hypoxia-inducible factor 1) [3].
Under normoxia the alpha subunit of HIF1 (HIF1A) is degraded
via ubiquitin-dependent proteolysis. Hypoxia leads to the stabili-
zation of the HIF1A protein and thereby initiates an orchestrated
signaling response affecting the expression of direct and indirect
target genes. The primary target genes of HIF1 are the cytokines
VEGFA (vascular endothelial growth factor A) and EPO
(erythropoietin). VEGFA and EPO stimulate angiogenesis, and
EPO additionally enhances the production of red blood cells.
Endothelial cells are the predominant target of VEGFA, because
of their ability to grow towards a hypoxic region following a
VEGFA gradient and thereby forming new blood vessels [4,5].
The cellular signaling response to hypoxia needs to be tightly
regulated, since already a small deviation of the balance between
pro- and anti-angiogenic factors can cause several severe diseases
such as ocular and inflammatory disorders. The ‘‘Von Hippel-
Lindau’’ disease is caused by the non-degradation of HIF1A under
normoxic conditions and results in the progressive growth of
several cancer types such as hemangioblast or renal cell carcinoma
upon excessive proangiogenic signaling [6].
In addition to the transcriptional response, hypoxia can also
modulate posttranscriptional and posttranslational events. In
recent years the importance of mRNA stability and translational
control came into focus, and several miRNAs and RNA-binding
proteins have been shown to implement the hypoxic gene
expression profile [7].
Up to 95% of all human genes are alternatively spliced [8,9].
Alternative splicing serves as regulatory platform that allows for
tissue specific expression and dramatically increases genomic
complexity. In addition, aberrant alternative splicing is the cause
of several diseases and appears to be involved in cancer
progression [10–12]. Next to deep sequencing, exon arrays, like
the GeneChip Exon Array from Affymetrix, make it possible to
assess alternative splicing on a genome-wide scale. In contrast to
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induced by hypoxia (for examples see [13–18]), only two
genome-wide analyses of hypoxia-related changes in pre-mRNA
splicing have been performed. One identified lama3 as a hypoxia-
related splice variant in head and neck cancers [19]. Another study
identified several alternative splice events in endothelial cells using
CoCl2 as hypoxia mimic and inducer of apoptosis [20].
So far, no genome-wide study investigated changes in splicing
events under low oxygen conditions. Therefore, we used the exon
array technology to examine hypoxia-related alternative splicing in
HUVECs. In combination with RT- and qRT-PCR experiments,
we validated alternative splicing for nine genes. None of them had
been associated with hypoxia before.
Results
Exon array analysis
We performed an Affymetrix GeneChip Human Exon 1.0 ST
Array to identify alternative splicing events during hypoxia in
HUVECs. In contrast to traditional microarrays, where probes
hybridize only to the 39-end of genes, exon arrays contain probe
sets targeting every exon over the entire length of the transcript.
One probe set consists of up to four individual probes targeting the
same exon. Additionally, larger exons are targeted by multiple
probe sets. Therefore, exon arrays allow the simultaneous
assessment of whole transcript and single exon levels.
Confluent HUVECs were incubated in triplicates for 48 h
under normoxic (21% O2) or hypoxic (1% O2) conditions. Total
RNA was isolated and tested for vegfa mRNA expression, to
confirm the response of the endothelial cells to hypoxia. qRT-PCR
analysis showed a 6-fold induction of vegfa mRNA levels under
hypoxic compared to normoxic conditions (Figure 1A). In
addition, the influence of the hypoxic conditions on apoptosis
was assessed (Figure 1B). Three independent experiments (con-
ducted in duplicates) show a low percentage of apoptotic cells, with
even a slight decrease in apoptosis during hypoxia.
The exon array analysis was conducted on the core probe sets
using the Exon Array Analyzer (EAA) Web interface [21]. Analysis
was performed with two different algorithms (RMA and Iter-
PLIER) for background correction and signal estimation. Only
genes/probe sets, which showed at least a 2-fold change in
expression and a p-value,0.01 were considered for further
analysis.
Using RMA, 296 genes were identified to be differentially
expressed. In contrast, Iter-PLIER revealed more than twice the
number (650 genes). Comparing the results of the two algorithms,
we found that 99% (294) of the genes shown to be differentially
expressed using RMA were also identified by Iter-PLIER. Only
genes identified by both algorithms were chosen for further
analysis.
Of the 294 regulated genes, 86 (29%) are up- and 208 (71%) are
downregulated under hypoxic conditions (Tables S1 and S2). GO
analysis was performed on these two groups using DAVID
Bioinformatics Resources 6.7 (http://david.abcc.ncifcrf.gov/)
[22,23]. Upregulated genes are most highly enriched for genes
responsive to hypoxia or related to hexose metabolism (Table 1).
Furthermore, several genes for cell migration, angiogenesis, tube
development and response to wounding are induced upon hypoxia
(Table 1). This relates to the function of HUVECs in blood vessel
development. Downregulated genes, however, are almost exclu-
sively related to the cell cycle, DNA replication or DNA repair
(Table 2).
When comparing our gene expression changes with a micro-
array performed by Scheurer et al. [16], where HUVECs were
kept under similar hypoxic conditions (48 h, 2% O2), the results
agree remarkably, despite the fact, that different array platforms
have been used. 246 genes out of the 294 identified genes are also
detected by the microarray platform. From these 57% and 63%,
respectively, of the up- and downregulated genes are identified in
both studies with a p-value,0.01. In comparison using the same
selection criteria as used in our study (.2-fold change, p-
value,0.01, predicted by both RMA and Iter-PLIER) only 3%
of the upregulated and 25% of the downregulated genes are found
in the study by Hang et al. [20], who used the same exon array
platform to study alternative splicing in HUVECs using CoCl2 as
hypoxia mimic and inducer of apoptosis. A similarity is that in all
three studies considerably more genes are downregulated (between
2.4- and 4.5-fold more).
Hypoxia-induced alternative splicing
Analysis of the expression of individual probe sets with RMA
showed 189 probe sets, whereas Iter-PLIER showed 474, with a
change of expression of .2-fold and a p-value,0.01 (Figure 2). In
contrast to the results on transcript level, where nearly all genes
found by RMA are also identified by Iter-PLIER, the overlap on
probe set level is only 32%. The calculation of the differential
Figure 1. Validation of hypoxic conditions by vegfa expression. A) Array probes (triplicates) were analyzed for vegfa expression using qRT-
PCR. Vegfa mRNA expression is normalized to the mRNA of the ribosomal Protein RPLP0, which expression does not change under hypoxia. Oxygen
starvation (open bar) leads to a 6-fold induction of vegfa compared to normoxic conditions (closed bar). *=p-value,0.05 (Student’s t-test). B) The
influence of the hypoxic conditions on apoptosis was assessed. Three independent experiments conducted in duplicates show a decrease of
apoptotic cells under hypoxia (open bars) compared to normoxia (closed bars).
doi:10.1371/journal.pone.0042697.g001
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probe set as well as the normalized gene level. Therefore, different
background correction strategies as implemented in RMA and
Iter-PLIER affect the expression signals at both levels, ultimately
resulting in different predictions. Still we think that combination of
both algorithms is beneficial, due to the fact, that both have
different strength and limitations in the detection of alternative
splicing events [24]. The 61 differentially expressed probe sets
identified by both algorithms are distributed over 52 genes (Table
S3) and cluster in four groups (Figure 2):
15 probe sets are the very first or very last probe set on the
respective mRNA. Here, differential expression would lead to
shorter or longer untranslated regions (UTRs) potentially modu-
lating gene expression. We tested six of these probe sets for
differential expression by comparing their expression under
normoxic and hypoxic conditions to the rest of the mRNA.
Primer pairs were designed amplifying either the extreme 59
(adssl1, dnmt1, mme, ucp2)o r3 9 (sdc2, smarca1) ends (the region
indicated by the putative differentially expressed probe set) or a
section of the open reading frame (ORF). All primer pairs showed
Table 1. GO analysis of upregulated genes.
GO term p-value Gene symbols
0001666,response to hypoxia 4.0610
28 adm, aldoc, angptl4, bnip3, cxcr4, egln3, pdgfb, pgf, vegfa, vldlr
0045429,positive regulation of nitric oxide
biosynthetic process
5.6610
23 igf2, icam1, insr
0019318,hexose metabolic process 7.7610
25 aldoc, eno2, gbe1, hk2, igf2, pdk1, pfkfb3, pgm1
1
0015758,glucose transport 0.011 igf2, slc2a1, slc2a3
0032868,response to insulin stimulus 2.1610
23 adm, igf2, insr, pparg, vldlr
0006090,pyruvate metabolic process 0.022 eno2, pgm1, slc16a3
0046942,carboxylic acid transport 0.045 pparg, slc16a3, slc6a6, slc7a2
0042981,regulation of apoptosis 3.7610
23 adora2a, angptl4, bnip3, dusp1, igf2, inhba, pde3a, pim1, ptgis, timp3,
tnfsf15, vegfa
2
0008285,negative regulation of cell proliferation 0.013 adm, adora2a, mxi1, nox4, pparg, tgfb1i1, tnfsf15
0030335,positive regulation of cell migration 1.2610
24 icam1, igf2, insr, pdgfb, vegfa, vegfc
0001525,angiogenesis 1.2610
23 angptl4, cxcr4, cyr61, pgf, vegfa, vegfc
0035295,tube development 6.6610
23 cxcr4, cyr61, lox, pgf, spry1, vegfa
0009611,response to wounding 7.7610
23 adm, adora2a, cxcr4, fbln5, igf2, lox, nox4, pdgfb, timp3
0008015,blood circulation 0.018 adm, adora2a, npr3, pparg, vegfa
0030198,extracellular matrix organization 0.019 cyr61, fbln5, lox, p4ha1
0007568,aging 0.022 adm, aldoc, nox4, timp3
1Underlined genes match to the GO term: 0006096,glycolysis (p-value=2.1610
23).
2Underlined genes match to the GO term: 0043066,negative regulation of apoptosis (p-value=0.012).
doi:10.1371/journal.pone.0042697.t001
Table 2. GO analysis of downregulated genes.
GO term p-value Gene symbols
0007049,cell cycle 2.9610
242 anln, aspm, aurka, aurkb, brca1, bub1, bub1b, ccna2, ccnb1, ccnb2, ccnd1, ccne2,
cdc2, cdc20, cdc45l, cdc6, cdca2, cdca8, cdkn3, cenpe, cenpf, cep55, ckap2, cks2,
clspn, dhcr24, dlgap5, exo1, fam83d, fancd2, fbxo5, foxm1, gmnn, hells, hjurp,
kif11, kif15, kif18a, kif20b, kif23, kif2c, map2k6, mcm6, mki67, ncapd3, ncapg,
ncaph, ndc80, nuf2, nusap1, pbk, plk1, prc1, pttg1, racgap1, rad51, sesn3, sgol1,
sgol2, ska1, ska3, spag5, spc25, tacc3, tpx2, trip13, ttk, txnip, uhrf1, zwilch, zwint
0006260,DNA replication 2.8610
214 brca1, ccne2, cdc45l, cdc6, cenpf, clspn, dtl, fen1, gins1, gins2, gins3, mcm10,
mcm4, mcm6, pcna, pole2, rad51, rfc3, rrm2, tk1, top2a, tyms
0006281,DNA repair 6.2610
27 brca1, brip1, clspn, exo1, fancd2, fen1, neil3, pcna, pole2, pttg1, rad51, rad51ap1,
rfc3, top2a, trip13, tyms, uhrf1
0031497,chromatin assembly 1.5610
26 asf1b, hells, hist1h1a, hist1h1b, hist1h2al, hist1h2bf, hist1h2bm, hist1h3a,
hist1h3b, hist1h3c, hist1h3h, hist1h3j, hist2h2ab, hjurp
0006979,response to oxidative stress 0.018 dhcr24, hmox1, nqo1, pla2g4a, stat1, txnip, ucp2
1
0042981,regulation of apoptosis 0.048 brca1, cdc2, dhcr24, hells, hmox1, hspa1a, map2k6, nme1, nqo1, pla2g4a,
serpinb2, sgk3, sort1, stat1, tnfsf18, top2a, txnip
2
0048015,phosphoinositide-mediated signaling 1.5610
27 aurka, bub1b, cks2, fen1, ndc80, pcna, pik3c2b, spag5, top2a, tyms, zwint
1Underlined genes match to the GO term: 0000302,response to reactive oxygen species (p-value=0.015).
2Underlined genes match to the GO term: 0043066,negative regulation of apoptosis (p-value=0.036).
doi:10.1371/journal.pone.0042697.t002
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different to the corresponding ORF (see for example ucp2, Figure
S1).
In eight cases only one of several probe sets corresponding to
the first or last exon of a mRNA shows differential expression,
while the other probe sets remain at a constant level. We tested
two (vegfa, adamts1) of these exons for differential expression, but
they behave like the remainder of the respective mRNA (induction
for vegfa, reduction for adamts1). Therefore we speculate that most
of the probe sets from these two groups are false positives.
13 changed probe sets correspond to exons annotated as
constitutive. They were not analyzed further, albeit it is possible
that they are indeed alternatively spliced. In seven cases, skipping
of the constitutive exon would target the mRNA to nonsense
mediated decay and consequently not lead to protein expression.
The other six cases could produce an alternative protein isoform
(Table S3).
25 of the 61 probe sets correspond to known exon skipping,
intron retention, alternative promoter or polyadenylation events
(Figure 2). We chose 19 of these for further validation.
Alternatively spliced cassette exons
Cassette exons account for about 40% of the alternative splicing
events in higher eukaryotes [25]. We tested six of the ten predicted
alternatively spliced cassette exons for differential expression under
normoxic and hypoxic conditions. We validated alternative
splicing for cask, sptan1 and pign by radioactive RT-PCR
(Figure 3) and for pign also by isoform-specific qRT-PCR
(Figure 3D). In all three genes the cassette exons are included at
a lower frequency upon hypoxia treatment. The predicted
alternative splicing event could not be validated for acot7, rfx3
and stil (data not shown). Here, either only one isoform was
detected or there was no change in the ratio of the two isoforms
comparing expression at normoxia and hypoxia.
CASK (calcium/calmodulin-dependent serine protein kinase) is
a membrane-associated guanylate kinase located at neuronal
synapses and cell-cell-junctions. Mutations result in X-linked
mental retardation [26] and the knockout of cask in mice is
neonatal lethal [27]. CASK is a multidomain protein coding N-
terminal for a CaM kinase II domain and C-terminal for PDZ,
SH3 and guanylate kinase-like domains. CASK binds the
proangiogenic factor SDC2 (syndecan 2) [28,29] as well as the
cytoskeletal adaptor protein EPB41 (protein 4.1) [28] and thereby
links components of the extracellular matrix to the intracellular
cytoskeleton. It is also involved in the regulation of cell growth [30]
and transcription [31]. The two detected isoforms of CASK
(Figure 3B) differ in 23 amino acids (aa) in the linker region
between the PDZ and SH3 domains (Figure S2A). In this case,
alternative splicing modulates domain spacing, which may
influence the ability of both domains to engage in protein binding
simultaneously. In addition, the skipped linker region harbors a
putative PEST-Element, which might influence proteasome-
dependent degradation [32]. As a result, alternative splicing
would directly impact on protein stability.
Sptan1 (alpha-II spectrin or alpha-fodrin) is specifically ex-
pressed in non-erythrocytic cells. Spectrins are essential compo-
nents of the cytoskeleton, composed of alpha- and beta-spectrins,
which form heterotetramers and directly bind to filamentous actin.
Spectrins associate with EPB41, WAS (Wiskott-Aldrich syndrome
protein, also WASP) and junction proteins like TJP1 (tight
junction protein 1, also ZO-1), CTNNA1 (alpha-catenin) and
GJA1 (gap-junction protein alpha 1, also connexin-43). Apart from
several spectrin repeats, which allow for tetramerization with the
beta-subunit, sptan1 codes for two EF hand motives and an SH3
domain. The two detected isoforms (Figure 3C) differ in a 20 aa
insertion C-terminal of the SH3 domain (Figure S2B). The longer
isoform, which is downregulated under hypoxic conditions, has
been shown to associate with GJA1 and to be required for its
localization to gap junctions [33]. The binding depends specifically
on the 20 aa insertion and may be sensitive for phosphorylation by
MAPK8 (JNK).
PIGN is involved in the glycosylphosphatidylinositol (GPI)-
anchor biosynthesis. It transfers phosphoethanolamine to the first
mannose of the GPI-anchor. The GPI-anchor is a glycolipid
attached to the C-terminus of target proteins in the endoplasmatic
reticulum. After secretion GPI-anchored proteins stay attached to
the membrane and protrude into the extracellular space.
Anchored proteins include the proangiogenic factors CDH13 (T-
Figure 2. Analysis of hypoxia induced alternative splicing. Differentially expressed probe sets are given in bold. The number of the
corresponding genes is given in brackets.
doi:10.1371/journal.pone.0042697.g002
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of pign does not result in different protein isoforms, but in two
59UTRs, which differ in 77 nucleotides (nt) in length (Figure 3D).
Hypoxia downregulates pign expression; especially the longer
59UTR isoform. Different 59UTRs can impact on the translational
efficiency of the mRNA, due to secondary structures, protein
binding sites, internal ribosome entry sites or upstream open
reading frames (uORFs). Therefore, the alternative splicing of the
59UTR of pign might influence protein expression under hypoxia.
Alternative polyadenylation
More than 50% of all human genes exhibit multiple poly(A) sites
[36]. Alternative polyadenylation (APA) can affect 39UTR length,
influencing e.g. mRNA stability by changing miRNA and protein
binding sites, or changing the protein coding capacity of an
mRNA. APA is regulated during proliferation and differentiation
and aberrant APA can be the causative agent of cancer [37]. Often
APA is associated with alternative splicing. We tested two of the
three predicted APA events (Table S3) and validated both (see itsn1
in Figure 4A and S3A; larp6 in 4B and S3B). In both cases
alternative splicing and APA lead to an altered C-terminus of the
encoded protein.
ITSN1 (intersectin 1) is an adaptor protein involved in endo-
and exocytosis, signal transduction and cytoskeleton remodeling.
Itsn1 codes for a long (ITSN1-L) and a short protein isoform
(ITSN1-S). Hypoxia specifically leads to the upregulation of the
long isoform ITSN1-L (Figure 4A), but not of ITSN1-S. ITSN1
knockout mice, either a complete knockout or only knockout of
ITSN1-L, are viable but show defects in vesicle trafficking and
alterations in the level of NGF (nerve growth factor) [38]. ITSN1-
S consists of two EH1 domains, a coiled-coil region and five SH3
domains. The by ten exons longer isoform ITSN1-L contains three
additional domains: DH (DBL homology domain), PH and C2
and shows GEF (guanine nucleotide exchange factor) activity
towards the proangiogenic factor CDC42, bringing it into the
active GTP-bound form [39].
LARP6 (La-related protein 6 or acheron) is structurally related
to La/SSB (Lupus erythematosus and Sjogren Syndrome antigen).
It codes for three La motives and one RRM domain, which both
are important for RNA-binding. It regulates the translation of
collagen mRNAs by binding to a conserved stem-loop in the
59UTR [40]. LARP6 was shown to regulate cell adhesion and
motility in myoblasts [41], as well as cell proliferation and
apoptosis in endothelial cells [42]. Larp6 codes for two protein
isoforms: one full-length (isoform 2 in Figure 4B) and one short
isoform (isoform 1), which is downregulated under hypoxic
conditions (Figure 4B). Isoform 1 is highly expressed under
normoxic conditions, but does not code for any known protein
domain. It consists of only two exons: it shares exon 1 (66 aa) with
the full-length protein and contains a unique exon 2, which codes
for additional 27 aa. Exon 2 does not seem to be evolutionary
conserved, not even among primates.
Intron retention
Intron retention is the rarest alternative splicing event in
humans [25]. We tested both of the introns predicted to be
differentially expressed (Table S3) and validated alternative
splicing for max (Figure 4C and S4). The retained intron in the
39UTR of zwint was expressed at a similar level as the remaining
mRNA, but did not show an increase under hypoxic conditions. In
contrast, it showed the same reduction as the complete mRNA
(Table S2).
Figure 3. Hypoxia-dependent alternative exon inclusion. A) Scheme of alternative splicing of cassette exons. Introns are represented as black
lines; constitutive exons as grey boxes and the cassette exon as white box. Primers are indicated as arrows and span the alternatively spliced exon.
Cassette exons in cask (B), sptan1 (C) and pign (D) are more often skipped under hypoxic then under normoxic conditions. Radioactive RT-PCR:
N=normoxia, H=hypoxia, M=DNA size ladder. The precentage of exon inclusion is given below. SD=standard deviation. qRT-PCR: closed
bars=normoxia, open bars=hypoxia. Two isoform specific forward primer (i1 and i2) spanning the exon/exon borders and one common reverse
primer (i1/2) were used. Expression is normalized to rplp0. Results from n=3 experiments are shown. *=p-value,0.05, **=p-value,0.01 (Student’s t-
test).
doi:10.1371/journal.pone.0042697.g003
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the basic helix-loop-helix leucine zipper family. MAX can either
form homodimers or heterodimers with other family members,
like MXD1 (also MAD), MXI1, MNT and MYC. The different
types of dimers compete for a common binding site (E box) in
promoter regions. MAX-MYC dimers transcriptionally activate
the target genes, leading to cell proliferation, but also sensitize cells
to apoptosis [43]. In contrast, heterodimers with other factors, like
the upregulated MXI1 (Table S1) act as transcriptional repressors,
therefore (at least partially) counteracting MYC activity [43]. In
endothelial cells overexpression of MAX antagonizes serum-
induced apoptosis [44]. Intron retention between exons 4 and 5
Figure 4. Hypoxia-dependent alternative C-termini. RT- and qRT-PCR analyses show changed expression of protein isoforms for itsn1 (A), larp6
(B) and max (C). Alternative splicing and polyadenylation lead to the expression of isoforms with different C-termini in istn1 (A) and larp6 (B). In the
case of max (C) due to intron retention an alternative stop codon is introduced, also leading to a different C-terminus. Schemes of alternative splicing
events: Introns are represented as black lines; exons as boxes; primer pairs (arrows) used to amplify different isoforms (i1, i2) or total amounts of the
mRNAs (t) are indicated. White exons indicate isoform 1, which expression is changed under hypoxic conditions. Grey exons are common to both
isoforms and primers spanning such regions were used to visualize changes in the total amount of the corresponding mRNA. In the case of larp6 only
the first exon is common to both isoforms, therefore isoform 2 (black exon) was visualized instead of the total mRNA amount, using one common
forward- and two isoform-specific reverse-primers. The primer pair recognizing the retained intron in the max mRNA could yield the same product
with genomic DNA. To ensure sample purity and exclude falsification of the results by contamination with genomic DNA, we performed the same RT-
(Figure S5) and qRT-PCR experiments with not reverse transcribed RNA (data not shown). These experiments yielded no product at all confirming the
observed increase is due to intron retention. RT-PCR: N=normoxia, H=hypoxia, M=DNA size ladder. qRT-PCR: closed bars=normoxia, open
bars=hypoxia. Expression is normalized to rplp0. Results from n=2 (RT-PCR) and n=3 (qRT-PCR larp6) or n=6 (qRT-PCR itsn1 and max) experiments
are shown. *=p-value,0.05, **=p-value,0.01 (Student’s t-test).
doi:10.1371/journal.pone.0042697.g004
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hypoxia-induced isoform (isoform 1) shares the first 98 aa with the
full-length protein (160 aa). It codes almost for the complete DNA-
binding domain, but contains a unique C-terminus (36 aa). How
the altered C-terminus impacts on protein function is unknown. A
different C-terminal isoform, where only part of the intron is
retained, and which also contains the first 98 aa, is still capable of
MYC-binding [45]. However, in contrast to the full-length
protein, it harbors no functional nuclear localization signal, but
relies on nuclear translocation by binding to MYC. In addition,
instead of repressing the transforming activity of MYC, like full-
length MAX, it enhances it.
Alternative promoter selection
30–50% of all human genes are transcribed from more than one
promoter [46]. Alternative promoter selection (APS) leads to the
expression of mRNA isoforms with different 59UTRs, implicated
in translation efficiency, or ORFs, which differ in their N-termini.
Aberrant use of alternative promoters has been studied in several
disease-related genes and is linked to cancer progression [46]. We
tested three (cugbp1, tpm1, robo1) of the four APS events triggered
through hypoxia and validated all of them (Figure 5).
Cugbp1 (CUG-repeat binding protein 1 or CELF1) encodes a
RNA-binding protein comprised of two N-terminal and one C-
terminal RRM domains, separated by a serine-rich region.
CUGBP1 is implicated in alternative splicing, mRNA decay and
translation. A recent study identified over 600 targets of CUGBP1
by co-immunoprecipitation [47]. Many contain so-called GRE
(GU-rich element) sequences in their 39UTR, which are bound by
CUGBP1 and promote rapid degradation of the mRNA. Cardiac-
specific overexpression in adult mice results in premature lethality
and cardiomyocyte pathology [48]. Hypoxia leads to the
downregulation of an N-terminally prolonged protein isoform
(isoform 1, Figure 5A). It is unknown how these additional 27 aa
impact on protein function. However, evolutionary conservation
and differential expression from the different promoters during
mouse myogenesis [49] hints to a distinct functionality of the
hypoxia regulated isoform.
TPM1 (alpha-tropomyosin) is an actin-binding protein, involved
in the contractile system of muscles and the cytoskeleton of non-
muscle cells. It consists of two alpha-helices assembled into dimeric
coiled-coils. Tpm1 (and also the other three tropomyosin genes) is
transcribed from two independent promoters, leading to the
expression of high (HMW) and low (LMW) molecular weight
isoforms. In addition, alternative splicing generates more than 40
tropomyosin isoforms in non-muscle cells. The various tropomy-
osin isoforms have a different intracellular localization, leading to
functionally distinct actin filament populations [50]. Hypoxia
specifically downregulates the LMW isoforms of tpm1 (isoform 1,
Figure 5B), but upregulates the total amount of alpha-tropomy-
osin. The increase in tpm1 expression was correctly predicted by
both Iter-PLIER (2.01-fold, p-value,0.01) and RMA (1.67-fold,
p-value,0.01), but is not included in Table S1, due to the less then
2-fold induction predicted by RMA. This increase results in a shift
towards HMW isoforms, which have been shown to possess tumor
suppressor functions and are downregulated in cancer cells [50].
LMW isoforms probably function in cell-cell adhesion and
exocytosis [50]. In addition, tropomyosins regulate actin filament
dynamics, impacting on cell migration by interfering with Arp2/3
driven actin branching [51].
Robo1 (roundabout 1) codes for a membrane receptor mediating
SLIT-induced repulsion on axon guidance, which plays an
important role in angiogenesis [52]. The extracellular part of
ROBO1 contains five immunoglobulin-like and three fibronectin
type III domains. The protein further codes for one transmem-
brane region, as well as four conserved motives and a serine-rich
region in the cytoplasmic part. Hypoxia downregulates robo1
expression, especially the N-terminally longer isoform (isoform 1,
Figure 5C). A slight downregulation to around 60% (p-
value,0.01) of the total amount of robo1 expression was correctly
predicted by both Iter-PLIER and RMA. The SLIT ligands bind
to the first two Ig domains in the N-terminal part of the protein
[53]. Therefore, the N-terminal extension might impact on ligand
affinity. Moreover, the reduction of isoform 1 may interfere with
the known homo- and heterodimerization of ROBO receptors.
Differential expression of two N-terminally distinct isoforms has
also been shown for ROBO2 and 3 [54,55]. In zebrafish the
ROBO3 isoforms have distinct functions in axon pathfinding and
dorsoventral cell fate specification [54]. For the human ROBO3
isoforms differential SLIT binding has been shown in vitro [56].
The function of the two ROBO1 isoforms is unknown, but
evolutionary conservation and differential expression during
mouse embryogenesis [57,58] hint at distinct functionalities.
Taken together, we show alternative splicing of nine genes upon
hypoxic treatment in endothelial cells; resulting in eight different
protein isoforms and one alternative 59UTR. Altogether 27 probe
sets were tested for differential expression and 15 of them
confirmed, corresponding to a validation rate of 56%. Considering
only probe sets related to known alternative exons (19 probe sets)
the validation rate amounts to 80%, due to the fact that all 15
validated probe sets belong to this group.
Discussion
We analyzed gene expression and splicing changes in endothe-
lial cells subjected to oxygen starvation (1%) for 48 h and showed
that hypoxia significantly changed alternative splicing decisions.
Whereas one previous study addressed the effect of hypoxia-
induced apoptosis on alternative splicing in endothelial cells [20],
this is to our knowledge the first study addressing the regulation of
splicing under physiological adaptation. Consistently, several genes
for which we showed alternative splicing are involved in the
regulation of cytoskeletal remodeling and migration.
Analyzing the functions of the genes validated to undergo
alternative splicing, we find several overlaps, like cellular
localization and involvement in cell motility. Two of the
alternatively spliced genes are essential parts of the cytoskeleton
(sptan1 and tpm1), which has to be remodeled to allow for cell
migration and angiogenesis. The downregulated splice isoform of
sptan1 has been shown to be important for the localization of GJA1
(connexin 43) to gap junctions in cardiomyocytes [33]. Previous
studies have shown that hypoxia reduces GJA1 expression,
phosphorylation and localization [59,60]. Downregulation of
GJA1 increases healing in a fibroblast wound-healing model by
accelerating cell migration and proliferation [61]. In addition,
Danesh-Meyer et al. [62] demonstrated that endothelial cell death
following hypoxia can be mediated by GJA1 hemichannel
opening. We therefore speculate, that alternative splicing of sptan1
positively contributes to cell survival and/or angiogenesis by the
reduction of gap junctions.
CDC42 is a small GTPase regulating actin polymerization by
signaling via WAS and WASL (also NWASP) to the Arp2/3
complex [63], which in turn is also regulated by the alternatively
spliced TPM1 [51]. CDC42 induces filopodia formation and is
specifically activated by the splice isoform of ITSN1 (ITSN1-L)
[39], which is upregulated by hypoxia. Therefore, alternative
splicing of ITSN1 likely leads to activation of the proangiogenic
factor CDC42.
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main heparan sulfate proteoglycan expressed on endothelial cells
and important for several steps of neovascularization [65]. CASK
is a multi-adaptor protein connecting SDC2 to the cytoskeleton
and has been shown to stabilize dendritic spines, developed from
SDC2-induced filopodia, in neurons [66]. CASK also binds to
LARP6 and seems to be connected to its positive effect on
HUVEC cell proliferation [42,67]. In addition, SDC2 has been
Figure 5. Hypoxia-dependent alternative N-termini. RT- and qRT-PCR analyses show alternative promoter usage for cugbp1 (A), tpm1 (B) and
robo1 (C) leading to protein isoforms with different N-termini. Schemes of alternative splicing events: Introns are represented as black lines; exons as
boxes; primer pairs (arrows) used to amplify different isoforms (i1, i2) or total amounts of the mRNAs (t) are indicated. White exons are exclusive for
isoform 1, which expression is changed under hypoxic conditions. Grey exons are common to both isoforms and primers spanning such regions were
used to visualize changes in the total amount of the corresponding mRNA. Black exons are exclusive for isoform 2, which is transcribed by an
alternative promoter. RT-PCR: N=normoxia, H=hypoxia, M=DNA size ladder. qRT-PCR: closed bars=normoxia, open bars=hypoxia. Expression is
normalized to rplp0. Results from n=2 (RT-PCR) and n=3 (qRT-PCR) experiments are shown. *=p-value,0.05, **=p-value,0.01 (Student’s t-test).
doi:10.1371/journal.pone.0042697.g005
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heterodimerizes with the endothelial specific ROBO4 and
positively regulates angiogenesis under normoxic conditions [69].
ROBO4 in turn has been shown to bind to WAS and WASL in
HUVECs [69]. The effects of the alternative splicing events in cask,
larp6 and robo1 remain unclear, however, we can speculate that
they might be involved in angiogenesis through activation of
CDC42.
When comparing our study with previously reported hypoxia-
related alternative splicing events, we find no overlap: lama3 was
identified in head and neck cancers [19], hif3a in mouse heart [70],
bnip3 in cardiac myocytes [71], cyr61 in several tumor cell lines
[72], psen2 in neuroblastoma cells [73] and pfkfb3 when comparing
different hypoxic mouse tissues [74]. This underlines the
importance and exclusiveness of tissue specific alternative splicing
events. But even when using the same cell line different hypoxic
conditions can trigger different splicing decisions: exon array
analysis following hypoxia-induced apoptosis in HUVECs identi-
fied 15 alternatively spliced genes [20], none of these were
identified in our analysis. In addition, we previously identified a
change in the ratio of short versus long flt1 mRNA isoforms after
hypoxia treatment [75]. Here HUVECs were incubated under
acute (0.1% O2) hypoxia, compared to the milder more
physiologic condition used in this study (1% O2), which does not
trigger alternative splicing of flt1 (data not shown). It seems that
more severe hypoxia, which is accompanied by apoptosis results in
different splicing events in endothelial cells.
Using very stringent selection conditions (.2-fold change, p-
value,0.01 and identification by two algorithms) only few
alternative splicing events (61 probe sets) were predicted in this
study. Identification of further splicing events could be achieved
e.g. by increase of the p-value to ,0.05, which would result in
around 3-fold more probe sets predicted to change expression. In
addition, we analyzed the highly curated core probe sets, but
extension of the analysis to all probe sets on the array will show
further alternative splicing events. Alternatively, RNA-seq could
be used for a complementary genome-wide study. RNA-seq has
been shown to be more sensitive in the detection of low abundant
exons [76]. In addition, direct comparison of the exon array
technology with RNA-seq showed only a small overlap of the
predicted alternative splicing events [76]. Therefore, a study using
RNA-seq might reveal further events during hypoxia.
In addition to provide novel insights into the changes of
alternative splicing in response to hypoxia, the results of the gene
expression analysis are consistent with previous studies. Thus,
under hypoxic conditions nearly 300 genes change their expres-
sion at least 2-fold. More than 200 of these genes are
downregulated and GO analysis revealed that most of them are
implicated in cell cycle and DNA replication. It has already been
demonstrated that hypoxia leads to G1 cell cycle arrest in different
cell types, by activation of cyclin-dependent kinase inhibitors and
downregulation of cyclins [77,78]. A microarray-based study
analyzed hypoxia-induced gene expression changes in HUVECs
at different time points [16]. Also here, prolonged hypoxia (48 h,
2% O2) led to a pronounced decrease of cell cycle-related genes,
several of which were also identified in the present study. In
addition, it is known, that hypoxia downregulates DNA repair
mechanisms [79], like mismatch repair, base excision repair,
homologous recombination and DNA-damage checkpoints of the
cell cycle (see Table 2 for examples). Upregulated genes are most
highly enriched in known hypoxia-related genes (Table 1), but also
in genes involved in hexose metabolism and angiogenesis, both
well-established features of hypoxia. Thus, the lists of up- and
downregulated genes recapitulate known responses to hypoxia.
Methods
Cell culture
Pooled HUVECs (Lonza) were grown in endothelial cell basal
medium (EBM), supplemented with EGM SingleQuots (both
Lonza) and 10% FCS (Gibco) in T75 flasks (Greiner). At the third
passage 1610
6 cells were seeded into 6 cm dishes (Greiner), after
18–24 h attachment supplied with fresh medium and incubated
for additional 48 h at normoxia or hypoxia (1% O2 in a Binder
CO2/O2 incubator).
RNA isolation
Total RNA was isolated using the miRNeasy Mini kit, including
the optional on-column DNA digestion with the RNase-Free
DNase Set (both Qiagen). After isolation 1 mg RNA was quality
checked on a 1% agarose gel.
Exon Array
Exon arrays were performed with three independent replicate
samples for each experimental condition by ATLAS Biolabs
(Berlin). Data analysis was performed on the raw CEL files using
the Exon Array Analyzer (EAA) Web interface (http://eaa.mpi-
bn.mpg.de/) [21] with the following settings: Species – Human;
Gene and Exon set – both core; Gene and Exon level
normalization – both either Iter-PLIER or RMA. The EAA uses
the Affymetrix Power Tools (APT) for preprocessing. Here either
RMA or Iter-PLIER were applied for normalization, background
correction and summarization to estimate exon and gene
intensities. The APT can also calculate the Detection Above
Background (DABG) p-values for each probe set. Before
alternative splicing is analyzed five filters are applied to reduce
false positives: (i) probe sets that are not expressed in one group are
removed. Probe sets are considered as ‘‘not expressed’’, if their
DABG p-value is .0.05 in .50% of the samples in one treatment
group; (ii) transcript clusters that are not expressed in both groups
are removed. Transcript clusters are considered ‘‘not expressed’’, if
.50% of their probe sets are undetected in .50% of samples in
one treatment group; (iii) probe sets for high potential for cross-
hybridization are discarded; (iv) transcript clusters with .10-fold
difference in gene expression are removed and (v) probe sets with
very large gene-level normalized intensity (.5) are removed.
Then, the Splice index (SI) is calculated for individual probe sets,
to analyze alternative splicing: SI=log2 (NI treatment group 1/NI
treatment group 2), with NI (gene-level normalized intensity)=p-
robe set intensity/transcript cluster intensity. Only transcript
clusters/probe sets changing.2-fold, with a p-value of ,0.01 and
predicted with both algorithms were chosen for further analysis.
The exon array data are available at the GEO database (accession
number GSE36837).
RT-PCR for mRNA isoform validation
For cDNA preparation 1 mg total RNA was reverse transcribed
using random hexamer primers (Fermentas) or oligo(dT) (T12,
Sigma-Aldrich) and MuLV reverse transcriptase (Applied Biosys-
tems) in the supplied buffer system (10 min at 25uC, 15 min at
42uC, 5 min at 99uC). After synthesis the reaction was diluted to a
final volume of 200 ml. For non-radioactive RT-PCR 5 ml cDNA
were used in a 30 ml PCR reaction with Taq polymerase (New
England Biolabs) in the supplied buffer system (95uC 30 sec, 55uC
30 sec, 72uC 30 sec, 32–38 cycles) and the products analyzed on a
3% agarose gel. Every isoform was confirmed in the samples used
for the exon array and one RNA sample from an independent
experiment (n=2). For radioactive RT-PCR the forward primer
was labeled using c-
32P-ATP (Hartmann Analytic) and T4
Hypoxia-Induced Alternative Splicing
PLoS ONE | www.plosone.org 9 August 2012 | Volume 7 | Issue 8 | e42697Polynucleotide-Kinase (Roche) in the supplied buffer system. Prior
to use primers were purified using MicroSpin G-25 columns (GE
Healthcare) and diluted 1:10 with unlabeled primer. The same
PCR conditions as for non-radioactive RT-PCR were used (30
cycles) and the products analyzed on a 6% polyacrylamid gel
(n=3). Exon inclusion was quantified using ImageQuant and a
Typhoon Phosphoimager (GE Healthcare). Primer sequences are
listed in Table S4. For validation all bands were gel purified and
subcloned for sequencing using the CloneJET PCR Cloning Kit
(Fermentas).
qRT-PCR quantification
qRT-PCR was performed on a StepOnePlus Real-Time PCR
System using the Fast SYBR Green Master Mix (both Applied
Biosystems). Primers are listed in Table S4. As internal control the
mRNA of rplp0 was used. For qRT-PCR quantification of mRNA
isoforms three to six RNA samples were prepared from
independent experiments other than for the exon array and RT-
PCR (n=3 or 6). Results are given as mean values 6 SD.
Analysis of apotosis
Cells were grown in duplicates under normoxic and hypoxic
conditions (n=3). Apoptosis was assessed using the FITC BrdU
Flow Kit (BD Biosciences) according to the manufacturer’s
protocol. Fixed and stained cells were analyzed on a fluorescence
activated cell sorter (FACS Canto II, BD Biosciences). Results are
given as mean values 6 SD.
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